GFI-Item5-CPP_Phase_2_Protocol-Dated_10Feb2018_Pages_1-40.pdf

PDF 1 MB Posted

Attached to
Cryopreserved Platelet (CPP) Development for U. S. Food and Drug Administration Licensure
Solicitation number
W81XWH19R0033
Issued by

About this file

Solicitation W81XWH19R0033 Government Furnished Information - Item 5 CPP Phase 2 Protocol Part 1 of 2

View the file

Other files

Show all 14

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Ad Hoc

Contamination of apheresis platelets

Leukoreduction during apheresis platelet collection.

Transfusion of blood components

Unintended thrombosis and thrombotic events associated with increased levels of pro-coagulation parameters associated with platelet cryopreservation sis and thromboticis and thrombotic parameters associaarameters associa ad hoc

File details come from the government source that posted it.